Posts tagged with "medical"

Advances That Can Prevent Stroke

Latest advances in stroke prevention replace older, less reliable methods. However, nearly half the country is still 10 years behind the times, says cardiologist Joshua S. Yamamoto, medical director at Foxhall Medicine in Washington, DC.

According to Dr. Yamamoto, the four major advancements everyone should know about are—

  1. The implantable cardiac monitor (made by Abbott/St Jude), which is a paper-clip-sized micro-chip that continuously monitors your heart and remotely alerts your doctor about significant irregularities.  “This is truly superior to the clunky wearable gear from the past,” says Dr. Yamamoto. As of 2019, it’s Medicare-approved for in-office insertion.  No preparation necessary.
  2. “DOACs,” Direct Oral Anti Coagulants.  This new class of “stroke prevention medications” is a million miles ahead of the old meds, like Warfarin/Coumadin.  This is not your Father’s Oldsmobile! The new meds are revolutionary. Here are the main benefits
    • Superior at preventing strokes
    • Lower bleeding complications
    • Have a stable dose that doesn’t require lab tests or constant adjustments (Nearly half the people taking Coumadin are not on the right dose, especially as the dose can change from week to week depending on your diet)
    • Starts immediately and stops or can be turned off quickly (Warfarin takes days to start and days to “reverse”)
    • Excellent absorption and efficacy with once-daily dosing
    • The only medications that prevent strokes for both atrial fibrillation AND arterial disease
  3. High resolution ultrasound (like for carotid studies) are much better than old-school imaging and can show disease progression. “In other words,” says Yamamoto, “this tech will let you know not just when to start treatment, but whether the treatment you are on is working well enough (for you) – all non-invasively and without radiation.”
  4. Functional testing, i.e., an exercise echocardiogram is an improvement on standard stress testing. “It is never just a pass/fail prospect. It tells you how effective your current therapy is and enables you to make adjustments.”  You don’t have to be an elite athlete to have a functional test, and again, there’s no invasive procedures, dye, injections or radiation.

How To Operate A Successful Medical Facility

Running a medical facility is incredibly important and noble work, and it can feel fantastic to make a difference to and save people’s lives every single day. On top of this, this will always be an industry that is in demand, which means it can be secure and lucrative work too. Running a successful medical facility is certainly not an easy task. You need to run the facility like a business while also providing the best possible care for your patients, which can be a tricky tightrope to walk. Below are a few points for running a successful medical facility.

1. Create A Strong Brand

Branding is the best way to differentiate yourself from the competition and show people your practice. In addition to the company logo, slogan, color scheme, and other branding factors, this will also involve how you welcome people through the door, how phones are answered and the general atmosphere that you want to create inside.

2. Recruit Carefully

In order to succeed in this industry, you need to provide an excellent level of care, which will mean having highly skilled employees at every level of the organization. In addition to attracting top talent, you will also need to look after your staff and keep them happy and motivated. It can be challenging in this industry because it is highly demanding, stressful and time-consuming work.

3. Purchase The Best Equipment

In addition to staff, being able to provide the best level of care will also involve having the latest and best medical equipment. Medical device engineering firms like DeviceLab provide prototypes of medical equipment which can help you to find the best products for your particular facility and stay ahead of the curve. In addition to medical equipment, utilizing the right software will help you to streamline the operation, reduce the workload of your staff and cut down on errors.

4. Invest In Marketing

As with any type of online business, online marketing is hugely important, along with having a high-quality website and being active on social media channels. It can increase brand awareness and allow you to directly communicate with the world and show why they should choose your facility over the competition. In addition to online marketing, you should also be looking at offline marketing as you will mainly be targeting people in the local area. This will involve traditional marketing such as adverts in the local paper but also by getting involved with the local community, holding local events and anything to get the face of the company out there.

Running a successful medical facility is a unique challenge as it is not like any other type of business. The key to success is providing the best level of care for your patients so that you can develop a good track record and show why people should choose your company over the competition. You can do this with the above tips, and when you start to find success, you will also find that this is incredibly rewarding work too.

Cure for Cancer in Israel

Cancer Researchers in Israel Believe They Will Have A Cure For Cancer In 1 Year

Promising Research with Multi-Agent Toxins

According to the WHO/International Agency for Research on Cancer, 18.1 million cancer cases are diagnosed worldwide each year. Cancer is now the second leading cause of death behind cardiovascular diseases. It is imperative now, more than ever, that we continue to seek new methods to treat this devastating illness.

Recently, Accelerated Evolution Biotechnologies did an interview where stated they believe that they will “offer in a year’s time a complete cure for cancer”. Although it grabs headlines, that is a momentous statement to make. Let’s dig a little deeper into the work that they are currently doing. The premise behind their treatment involves using a multi-agent target toxin treatment to treat cancer. In the past, this type of therapy targeted toxin treatment has involved the introduction of DNA coding for a protein (can be an antibody) into a bacteriophage – which is a virus that infects bacteria. These proteins can then be displayed on the surface of the virus and interact with its surroundings.
The company’s therapy involves a similar phenomenon, but with the use of peptides instead of proteins. Peptides consist of two or more amino acids linked together in a chain. They are smaller than proteins, can serve biological functions, and in many ways are less expensive to reproduce.

Most cancer therapies aim at attacking a target in a cell, on the surface of a particular cell, or in one of its internal pathways.

However, a mutation in one of these targets can make the therapy ineffective. What is being done here, with multi-target toxin therapy, is that several peptides of the cancer cell are being targeted with a peptide toxin to avoid mutations rendering a therapy ineffective. The more targets used, the less likely that a series of mutations will occur simultaneously that will make the therapy ineffective. This will help in not allowing the cancer cell to evade the treatment and continue to replicate, even with some mutations occurring.

This may have the ability to reduce side effects as well, given that the peptides will aim to attack specific targets on the cancer cells that are typically not overexpressed in other healthy cells. In addition, since the peptides are small (the ones they have developed are about 12 amino acids long) and lack a rigid structure, it allows them access to regions of the cell that may be blocked if a larger protein was used.

Overall, they are using a “combination modality” in a very specific manner for an attack of each cancer cell in this therapy. Combinational therapy has been successful before with cancer, HIV, and autoimmune disease among others. The goal of the company is to eventually personalize this to each patient by having a biopsy sent and analyzed for the receptors that it over expresses. The patient would then be administered an individualized concoction developed to treat the disease.

This is exciting and has potential, but more data needs to be presented. Thus far they have concluded mice experimentation and found inhibited human cancer cell growth that did not affect healthy mice cells. They are currently working on beginning a round of clinical trials, which many people will be eager to see the conclusions. Recently, Accelerated Evolution Biotechnologies has been writing patents on a variety of different specific peptides. While their work thus far is enthusing and making headlines, their claim to “offer in a year’s time a complete cure for cancer” is likely premature. Yet, I don’t know a single person, including myself, who wouldn’t hope for that.

Joshua Mansour, M.D. is a board-certified hematologist and oncologist in Stanford, California.  He is currently doing additional work in the field of Hematopoietic Stem Cell Transplantation and Cellular Immunotherapy.

Tom Kersting Licensed Psychotherapist

Tom Kersting is one of the most sought-after experts in the field of mental health, families, parenting in the digital age, and over-device use. Tom holds advanced degrees including a bachelor’s degree in Psychology from St. Thomas Aquinas College, a Master’s degree in Counseling & Human Development and a second Master’s in Administration & Supervision, both from Montclair State University. Tom also holds a Ph.D. in Clinical Hypnotherapy (alternative/non-traditional) from Kona University.

Tom is a spokesperson for Zift, your screen time parenting ally, which offers a comprehensive and free solution for families wanting a safe and healthy way to live with smartphones, social media, apps and other screen time media and devices. Zift’s free app provides parents with the ‘Family Feed’ – a quick and easy way to understand their children’s screen time activity in real-time – by alerting parents to online searches, app installations, and viewing of dangerous content. Through its Parent Portal found at WeZift.com, Zift provides parents and others entrusted with the care of children a place to learn about and discuss the latest topics related to screen time use, online safety, and social media. Zift Premium, which includes the Net Nanny® Smart Filter, offers the best protection, screen time scheduling and device control that parents need to help raise successful kids in a technology-driven world.

Endothelial progenitor cells for treating stroke patients

A new study recently published in STEM CELLS Translational Medicine demonstrates the long-term safety of laboratory-expanded endothelial progenitor cells for treating ischemic stroke. This could be good news for the 15 million people who, according to to the World Stroke Organization, suffer from this dangerous condition each year.

Ischemic stroke is the most common type of stroke, affecting nearly 90 percent of all cases. It is caused by a blocked blood vessel in the brain. In the normal central nervous system, endothelial progenitor cells (EPCs) play an active role in building blood vessels. This has led researchers to wonder whether EPCs circulating in the blood could be recruited after a stroke to assist in repairing damaged vessels in the brain. However, there is one major problem with this idea: The number of circulating EPCs is too low to provide much regenerative capacity – a number that further decreases in the aging or in those with heart problems.

This makes ex vivo (lab) expanded EPCs an attractive alternative.

“Transplantation of EPCs was already determined in animal experiments to be a safe and effective method for treating ischemic stroke. However, their safety and efficacy had yet to be determined in humans,” said Zhenzhou Chen, M.D., Ph.D., Southern Medical University, Guangzhou, China, and a corresponding author on the study. “In our trial, we tested the safety and feasibility of transplanting an acute ischemic stroke patient with his or her own (autologous) ex vivo expanded EPCs.”

Eighteen patients were recruited for the randomized, single-blinded study. Each received conventional treatment after their stroke then, seven days after symptom onset, underwent a bone marrow aspiration to collect EPCs and bone marrow stromal cells (BMSCs) for expansion in the lab. The patients were divided into three groups and, beginning at week four after the aspiration, one group was intravenously infused with their own EPCs, while the other two groups received either their own BMSCs or a saline placebo as the controls.

Each patient was then monitored for 48 months. Study co-author Xiaodan Jiang, M.D., Ph.D., also from Southern Medical University, explained, “We watched for mortality of any cause, adverse events and any new-onset diseases or conditions. Changes in neurological deficits were also assessed at different time points.”

In the end the researchers found no toxicity events nor did they see any infusional or allergic reactions in any of the patients. “The EPC group had less serious adverse events compared to the placebo-controlled group, although there were no statistical differences in mortality among the three groups,” Dr. Chen reported. “Ex vivoexpansion always raises concerns that it may cause instability in the chromosomes or maybe lead to tumors. However, in our long-term study we observed no increased tumorigenicity. This safety indicator was also confirmed by many animal studies and other trials using expanded bone marrow-derived stem cells for treatment of ischemic stroke.”

The researchers did note limitations in their study, including lack of patient-centered quality of life outcomes. “Moreover, because of the small size of the cohorts involved, we could neither identify the neurological or functional benefits of EPCs on ischemic stroke, nor determine the pros and cons between EPCs and BMSCs for stroke treatment,” Dr. Jiang said. “Thus, we believe a larger phase 2 trial is warranted.”

“This is a promising line of cell therapy research using a novel treatment method that is simple and non-invasive,” said Anthony Atala, M.D., Editor-in-Chief of STEM CELLS Translational Medicine and director of the Wake Forest Institute for Regenerative Medicine. “We look forward to larger phase 2 trial results.”

The full article, “Autologous endothelial progenitor cells transplantation for acute ischemic stroke: A four-year follow-up study,” can be accessed at http://www.stemcellstm.com.

About STEM CELLS Translational Medicine: STEM CELLS Translational Medicine (SCTM), published by AlphaMed Press, is a monthly peer-reviewed publication dedicated to significantly advancing the clinical utilization of stem cell molecular and cellular biology. By bridging stem cell research and clinical trials, SCTM will help move applications of these critical investigations closer to accepted best practices. SCTM is the official journal partner of Regenerative Medicine Foundation.

About AlphaMed Press: Established in 1983, AlphaMed Press with offices in Durham, NC, San Francisco, CA, and Belfast, Northern Ireland, publishes two other internationally renowned peer-reviewed journals: STEM CELLS® (www.StemCells.com), celebrating its 36th year, is the world’s first journal devoted to this fast paced field of research. The Oncologist® (www.TheOncologist.com), also a monthly peer-reviewed publication, entering its 23rd year, is devoted to community and hospital-based oncologists and physicians entrusted with cancer patient care. All three journals are premier periodicals with globally recognized editorial boards dedicated to advancing knowledge and education in their focused disciplines.

About Wiley: Wiley, a global company, helps people and organizations develop the skills and knowledge they need to succeed. Our online scientific, technical, medical and scholarly journals, combined with our digital learning, assessment and certification solutions, help universities, learned societies, businesses, governments and individuals increase the academic and professional impact of their work. For more than 200 years, we have delivered consistent performance to our stakeholders. The company’s website can be accessed at www.wiley.com.

About Regenerative Medicine Foundation (RMF): The non-profit Regenerative Medicine Foundation fosters strategic collaborations to accelerate the development of regenerative medicine to improve health and deliver cures. RMF pursues its mission by producing its flagship World Stem Cell Summit, honouring leaders through the Stem Cell and Regenerative Medicine Action Awards, and promoting educational initiatives.

Rock Solid Research On How To Prevent Dementia

Dr. Timothy R. Jennings speaks expertly on a subject that concerns over 5.5 million people across the nation: how to prevent dementia and keep our mind sharp as we age. A psychiatrist and international speaker, Jennings introduces his new book, recently rated #1 by Amazon in books on dementia, The Aging Brain: Proven Steps to Prevent Dementia and Sharpen Your Mind.

Dr. Jennings prescribes simple, everyday actions we can take to stave off disease, promote vitality, and prevent dementia and late-onset Alzheimer’s. “The choices we make now can help us to keep our minds sharp and maintain our independence as we age,” says Jennings.

An easy-to-use guide to maintaining brain and body health throughout life, The Aging Brain is based on solid, up-to-date scientific research, and the interventions discussed can prevent progression toward dementia, even in those already showing signs of mild cognitive impairment. The recommendations also may help reduce disability and depression.

“This book isn’t just for people hoping to slow the aging process,” says Jennings. “It’s also for anyone who is a caregiver to someone at risk of or already beginning to suffer from dementia. It offers a hopeful, healthy way forward.”

Jennings, who maintains a private practice in Chattanooga, TN, has authored several books, including The God-Shaped Brain and The God-Shaped Heart. He is a Distinguished Fellow of the American Psychiatric Association and Fellow of the Southern Psychiatric Association, and is president and founder of Come and Reason Ministries.

For more information about Dr. Jennings, please visit the website: https://www.agingbrainbook.com.

To connect with Dr. Jennings, please visit: https://www.facebook.com/DrTimJennings/ and https://twitter.com/timjenningsmd.

Why Some Women are Delaying Pregnancy

New findings from a recent survey show that women living with chronic inflammatory or autoimmune disease feel they don’t have enough information to make informed decisions about how to balance pregnancy with disease management. Some women feel they have no choice but to stop treatment or delay their plans for pregnancy. These women are living with a variety of autoimmune conditions including rheumatoid arthritis, psoriasis, psoriatic arthritis, ankylosing spondylitis and Crohn’s disease.

Now, a new initiative called the AIM (Autoimmune Motherhood) Movement is being launched to rally these women and provide support, information and a place for them to share stories about motherhood with chronic inflammatory disease. The education campaign and online community aims to help women learn the facts about their conditions and appropriate disease management options, while allowing them to share experiences to empower one another.

AIM Survey Shows:

  • Almost half (44%) of U.S. women surveyed had concerns serious enough that they delayed their plans to become pregnant
  • 61% believed they could not combine treatment and breastfeeding
  • Only 41% consulted a healthcare professional before becoming pregnant, suggesting the need for women to become more engaged in treatment and pregnancy planning earlier

On Wednesday, July 11th, join Dr. Grace Wright, rheumatologist at New York University Langone Medical Center and patient Rosanna, who shares her compelling story of living 30 years with rheumatoid arthritis and the physical and emotional challenges she endures while dealing with her disease. Both guests will help bring awareness to the issues surrounding ways to manage chronic inflammatory disease throughout the family planning journey. They’ll also reveal the results of the AIM Patient Survey to help others in similar situations make the best decisions for themselves and their families.

Martha Stewart

Watch: https://youtu.be/dG_W9K–Hz0

Did you know that the daily pill that saves your life if you’re living with HIV costs just 20 cents a day in sub-Saharan Africa? Highlighting the impact that just 20¢ can have on someone’s life, the new EAT (RED) SAVE LIVES PSA, featuring Martha Stewart, Padma Lakshmi, Elizabeth Falkner, Hannah Bronfman, Angie Mar, Dana Cowin and Hong Thaimee, reminds food fans worldwide the power of what two dimes can buy when you choose to EAT (RED) this June.

(RED)’s fifth annual culinary campaign features an exciting line-up of chefs, food and drink activations, dining experiences and products to turn people’s food and drink choice into a force to fight AIDS, by raising money and awareness for the Global Fund. There are so many ways for food fans worldwide to get involved June…

  • Eat out at restaurants like Blaze Fast Fire’d Pizza where you can order the (RED) VINE Pizza at more than 260 of its locations across the U.S, donating $1 for every order of a (RED) Vine and a Coke, up to $50,000.

  • Order in from Jeni’s Splendid Ice Creams who will offer a special (RED) Collection for the month of June. Featuring five lovingly made flavors – Coffee with Cream & Sugar, Goat Cheese with Red Cherries, Ricotta Toast with Red Berry Geranium Jam, Ndali Estate Vanilla and dairy-free Dark Chocolate Truffle – delivered straight to your doorstep, each purchase will generate $6 to fight

  • Attend a PlaceInvaders series of intimate pop-up events in New York and Los Angeles. Hosted in secret residential properties, each brunch and dinner seating will feature menus by NYC- and LA-based chefs including Angie Mar (The Beatrice Inn), Patti Jackson (Delaware & Hudson), Sara Kramer and Sarah Hymanson (Kismet and Mad Capra), Jessica Koslow (Sqirl) andMei Lin (Nightshade). Tickets include five courses, (BELVEDERE)REDcocktails, and Josh Cellars wine, and are priced between $120-$150, with $18 from every ticket sold going to fight AIDS – enough to provide 90 days of life-saving medication.

DISABILITY EMPLOYMENT

“People with disabilities are entering the workforce in unprecedented numbers?” It’s worth looking at the reports that show how “no group has felt the benefits of accelerated economic growth more than Americans with a disability”

Indeed, people with disabilities experienced a four-fold increase in job opportunities last year – unprecedented growth

In states across the country, Governors are undertaking new efforts to expand job opportunities for all. For example, Gov.Edwards recently launched a task force focused on employment for Louisianans with disabilities. Gov. Walker just signed historic legislation that makes Wisconsin an Employment First and commits resources to expanding competitive, integrated employment. Remarkable progress and remarkable leadership.

During the Meeting of the National Governors Association (NGA), our team and partner organizations spoke 1-on-1 with thirty-four different Governors. In each meeting we advocated for policies and practices that will expand economic opportunities. For several Governors, we had the chance to honor them with an award for their leadership and their continuing commitment to these issues.

At the end of the day, there are hundreds of self-advocates, community organizations and state leaders in a position to drive this change forward. Your involvement can move progress even faster! Expanding opportunities requires leaders across the public sector, the private sector and advocates to join forces and find solutions. First, check out where your state ranks and what challenges impact opportunities. You can also see what your state has done or is already doing to expand jobs for people with disabilities. We have written in-depth reports about what each of the 50 states is doing to advance opportunities for Americans with disabilities. image-2018-04-18 (1)

Dairy Queen Celebrates Spring

Dairy Queen Celebrates First Day of Spring With Free Cone Day on March 20

 

Participating locations will collect donations to Children’s Miracle Network Hospitals

 

WHO: Participating non-mall Dairy Queen and DQ Grill & Chill  locations throughout the United States 

 

WHAT: Will celebrate Free Cone Day on the first day of Spring. Fans will receive a FREE small vanilla soft-serve cone with the signature curl on top (limit one per customer while supplies last).

 

At participating locations, donations will be collected for Children’s Miracle Network Hospitals, which raises funds to help save and improve the lives of kids treated at 170 children’s hospitals across the U.S. and Canada.

 

Last year, more than $300,000 was raised during Free Cone Day.

 

WHEN: All day on Tuesday, March 20

 

WHERE: To find a participating location, contact information for Dairy Queen locations can be found HERE.

 
ADDITIONAL INFORMATION:

For more information about the Dairy Queen system, visit www.DairyQueen.com. Connect with the DQ system on Twitter using #LOVEmyDQ. Visit the DQ Facebook fan page, which has more than 11 million friends and become a friend.


###
About IDQ:
International Dairy Queen Inc., (IDQ), based in Minneapolis, Minnesota, is the parent company of American Dairy Queen Corporation. Through its subsidiaries, IDQ develops, licenses and services a system of more than 6,800 locations in the United States, Canada and more than 25 other countries. IDQ is a subsidiary of Berkshire Hathaway Inc. (Berkshire) which is led by Warren Buffet, the legendary investor and CEO of Berkshire. For more information visit DairyQueen.com.
About Children’s Miracle Network Hospitals:
Children’s Miracle Network Hospitals® raises funds and awareness for 170 member hospitals that provide 32 million treatments each year to kids across the U.S. and Canada. Donations stay local to fund critical treatments and healthcare services, pediatric medical equipment and charitable care. Since 1983, Children’s Miracle Network Hospitals has raised more than $5 billion, most of it $1 at a time through the charity’s Miracle Balloon icon. Its various fundraising partners and programs support the nonprofit’s mission to save and improve the lives of as many children as possible. Find out why children’s hospitals need community support, identify your member hospital and learn how you can Put Your Money Where the Miracles Are, at CMNHospitals.org and facebook.com/CMNHospitals.